Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.

Sign up for a 7-day FREE trial today!

Latest News in Intellectual Property

• February 04, 2026

  GM Brings Design Patent Suits Over Alleged Car Part Copies

  General Motors has launched a trio of lawsuits in both Michigan and Illinois federal courts, accusing a host of companies of infringing the auto giant's design patents by selling copies of its car parts.

• February 04, 2026

  Fed. Circ. Backs Infringement Immunity For NASA Contractor

  The Federal Circuit on Wednesday endorsed a California federal judge's decision that a NASA contractor doesn't have to face a patent infringement suit from a pair of California men, given that its allegedly infringing use was authorized by the federal government.

• February 04, 2026

  Music Labels Win On Most Counts In Classic Rock Videos Suit

  Music labels suing a British filmmaker and his former company over a set of videos that made unauthorized use of songs by several classic rock artists were granted a win on a substantial portion of the case Wednesday by a Manhattan federal judge who found the videos did not contain enough legitimate commentary to be considered documentaries.

• February 04, 2026

  Davis Polk Picks Up IP Ace From Debevoise & Plimpton

  Preeminent intellectual property attorney John "Jay" Neukom, who has a storied track record prevailing on behalf of major companies in high-profile legal battles across the country, has joined Davis Polk & Wardwell LLP in Northern California, after spending nearly four years with Debevoise & Plimpton LLC, according to an announcement made Monday.

• February 04, 2026

  Teva Fights Class Cert. Bid In Effexor Antitrust Case

  Teva Pharmaceuticals urged a New Jersey federal judge Wednesday to reject a class certification bid by a group of direct buyers of the antidepressant drug Effexor XR and its generic versions, arguing that the proposed class failed to carry its burden showing that joinder is impracticable.

See more Intellectual Property news